SCOPUS 정보 검색 플랫폼

Journal of Clinical Pharmacology

Volumn 39, Issue 12, 1999, Pages 1277-1282

A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam

(3) Sisson, T L a Jungbluth, G L a Hopkins, N K a

a PFIZER INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; LINEZOLID;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG METABOLISM; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0033309224 PISSN: 00912700 EISSN: None Source Type: Journal
DOI: 10.1177/00912709922011962 Document Type: Article

Times cited : (49)

References (19)

1
- 85037947603
- The oxazolidinone linezolid inhibits translation initiation in bacteria (abstract 5375). Paper presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, 28 September-1 October 1997, Toronto, Ontario
- Demyan, W.F.¹ Swaney, S.M.² Shinabarger, D.L.³

2
- 85037928439
- Oxazolidinone mechanism of action: Eperezolid inhibits the initiation event of protein synthesis in bacteria (abstract A-057). Paper presented at the 96th general meeting of the American Society for Microbiology, 19-23 May 1996, New Orleans, LA
- Swaney, S.M.¹ Shinabarger, D.L.²

3
- 0030793842
- Mechanism of action of oxazolidinones: Effects of linezolid and eperezolid on translation reactions
- (1997) Antimicrob Agents Chemother , vol.41 , pp. 2132-2136
- Shinabarger, D.L.¹ Marotti, K.R.² Murray, R.W.³ Lin, A.H.⁴ Melchior, E.P.⁵ Swaney, S.M.⁶

4
- 0030773903
- The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with the binding of chloramphenicol and lincomycin
- (1997) Antimicrob Agents Chemother , vol.41 , pp. 2127-2131
- Lin, A.H.¹ Murray, R.W.² Vidmar, T.J.³ Marotti, K.R.⁴

5
- 0023786135
- Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound
- (1988) Antimicrob Agents Chemother , vol.32 , Issue.9 , pp. 1341-1346
- Daly, J.S.¹ Eliopoulos, G.M.² Willey, S.³ Moellering R.C., Jr.⁴

6
- 0023876325
- Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds
- (1988) J Antimicrob Chemother , vol.21 , pp. 721-730
- Daly, J.S.¹ Eliopoulos, G.M.² Reiszner, E.³ Moellering R.C., Jr.⁴

7
- 0023838224
- The mechanism of action of DuP 721, a new antibacterial agent: Effects on macromolecular synthesis
- (1988) Biochem Biophys Res Comm , vol.150 , Issue.3 , pp. 965-971
- Eustice, D.C.¹ Feldman, P.A.² Slee, A.M.³

8
- 0023748768
- Mechanism of action of DuP 721: Inhibition of an early event during initiation of protein synthesis
- (1988) Antimicrob Agents Chemother , vol.32 , Issue.10 , pp. 1218-1222
- Eustice, D.C.¹ Feldman, P.A.² Zajac, I.³ Slee, A.M.⁴

9
- 0029942573
- In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
- (1996) Antimicrob Agents Chemother , vol.40 , pp. 839-845
- Zurenko, G.E.¹ Yagi, B.H.² Schaadt, R.D.³ Allison, J.W.⁴ Kilburn, J.O.⁵ Glickman, S.E.⁶

10
- 0029912276
- In vitro antimicrobial activity and spectrum of U-100592 and U-100766, two novel oxazolidinones
- (1996) Antimicrob Agents Chemother , vol.40 , pp. 720-726
- Jones, R.N.¹ Johnson, D.M.² Erwin, M.E.³

11
- 0002432831
- U-100766 safety, toleration and pharmacokinetics after oral and intravenous administration
- Abstracts of European Congress of Antimicrobial Chemotherapy
- (1996)
- Pawsey, S.D.¹ Daley-Yates, P.T.² Wajszczuk, C.P.³ Stalker, D.J.⁴

12
- 85037926834
- Linezolid safety, tolerance, and pharmacokinetics following oral dosing twice daily for 14.5 days. Paper presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, 28 September-1 October 1997, Toronto, Ontario
- Stalker, D.J.¹ Wajszczuk, C.P.² Batts, D.H.³

13
- 85037946423
- Linezolid safety, tolerance, and pharmacokinetics after intravenous dosing twice daily for 7.5 days. Paper presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, 28 September-1 October 1997, Toronto, Ontario
- Stalker, D.J.¹ Wajszczuk, C.P.² Batts, D.H.³

14
- 85037930896
- 14C] PNU-100766 to healthy volunteers. Paper presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 24-27 September 1998, San Diego, CA
- Feenstra, K.L.¹ Slatter, J.G.² Stalker, D.J.³ Welshman, I.R.⁴ Hauer, K.S.⁵ Cathcart, M.T.⁶

15
- 0023974280
- Clinical pharmacokinetics of aztreonam
- (1988) Clin Pharmacokinet , vol.14 , pp. 148-155
- Mattie, H.¹

16
- 0028082036
- Clinical pharmacokinetics of aztreonam: An update
- (1994) Clin Pharmacokinet , vol.26 , pp. 99-106
- Mattie, H.¹

17
- 0024400395
- Single-dose pharmacokinetics of aztreonam in healthy volunteers and renal failure patients
- (1989) J Chemother , vol.1 , pp. 164-169
- El Guanidine, M.A.¹ Nawishy, S.² Abd el Bary, M.³ Sabbour, M.S.⁴

18
- 0022395509
- Aztreonam, a new monolactam antimicrobial
- (1985) Clin Pharm , vol.4 , pp. 516-526
- Guay, D.R.¹ Koskoletos, C.²

19
- 0020294040
- Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,766) in healthy subjects
- (1992) Antimicrob Agents Chemother , vol.21 , pp. 944-949
- Swabb, E.A.¹ Sugerman, A.A.² Platt, T.B.³ Pilkiewicz, F.G.⁴ Frantz, M.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.